Norway Savings Bank Abb Vie Inc. Transaction History

Norway Savings Bank

$184 Million
Q3 2024

A detailed history of Norway Savings Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Norway Savings Bank holds 4,630 shares of ABBV stock, worth $812,935. This represents 0.5% of its overall portfolio holdings.

Number of Shares

4,630

Previous 4,680 1.07%

Holding current value

$812,935

Previous $802,000 13.97%

% of portfolio

0.5%

Previous 0.46%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$163.84 - $199.33 $8,192 - $9,966	-50 Reduced 1.07%	4,630 $914,000
Q2 2024 Jul 12, 2024	BUY	$154.79 - $180.76 $224,445 - $262,102	1,450 Added 44.89%	4,680 $802,000
Q1 2024 Apr 16, 2024	SELL	$159.82 - $182.1 $69,521 - $79,213	-435 Reduced 11.87%	3,230 $588,000
Q4 2023 Jan 12, 2024	SELL	$137.6 - $154.97 $10,320 - $11,622	-75 Reduced 2.01%	3,665 $567,000
Q3 2023 Oct 23, 2023	SELL	$133.59 - $154.65 $39,409 - $45,621	-295 Reduced 7.31%	3,740 $557,000
Q2 2023 Jul 11, 2023	SELL	$132.51 - $164.9 $110,248 - $137,196	-832 Reduced 17.09%	4,035 $543,000
Q1 2023 Apr 11, 2023	SELL	$144.61 - $166.54 $45,118 - $51,960	-312 Reduced 6.02%	4,867 $775,000
Q4 2022 Jan 10, 2023	SELL	$138.31 - $165.87 $3,181 - $3,815	-23 Reduced 0.44%	5,179 $837,000
Q3 2022 Oct 18, 2022	SELL	$134.21 - $153.93 $10,065 - $11,544	-75 Reduced 1.42%	5,202 $698,000
Q2 2022 Jul 15, 2022	SELL	$137.62 - $174.96 $8,945 - $11,372	-65 Reduced 1.22%	5,277 $808,000
Q1 2022 Apr 08, 2022	SELL	$131.98 - $163.75 $39,198 - $48,633	-297 Reduced 5.27%	5,342 $866,000
Q4 2021 Jan 18, 2022	SELL	$107.43 - $135.93 $44,690 - $56,546	-416 Reduced 6.87%	5,639 $764,000
Q3 2021 Oct 14, 2021	SELL	$106.4 - $120.78 $6,809 - $7,729	-64 Reduced 1.05%	6,055 $653,000
Q2 2021 Jul 15, 2021	SELL	$105.21 - $117.21 $17,990 - $20,042	-171 Reduced 2.72%	6,119 $689,000
Q1 2021 Apr 13, 2021	SELL	$102.3 - $112.62 $47,978 - $52,818	-469 Reduced 6.94%	6,290 $681,000
Q4 2020 Jan 13, 2021	BUY	$80.49 - $108.67 $36,381 - $49,118	452 Added 7.17%	6,759 $724,000
Q3 2020 Oct 14, 2020	SELL	$85.91 - $100.83 $1,718 - $2,016	-20 Reduced 0.32%	6,307 $552,000
Q2 2020 Jul 07, 2020	BUY	$73.37 - $98.18 $32,869 - $43,984	448 Added 7.62%	6,327 $621,000
Q1 2020 Apr 14, 2020	SELL	$64.5 - $97.79 $4,837 - $7,334	-75 Reduced 1.26%	5,879 $448,000
Q2 2019 Jul 11, 2019	SELL	$65.7 - $83.98 $5,913 - $7,558	-90 Reduced 1.49%	5,954 $433,000
Q1 2019 Apr 12, 2019	BUY	$77.14 - $90.79 $16,970 - $19,973	220 Added 3.78%	6,044 $487,000
Q4 2018 Jan 16, 2019	SELL	$77.85 - $96.01 $28,493 - $35,139	-366 Reduced 5.91%	5,824 $537,000
Q3 2018 Oct 16, 2018	SELL	$88.91 - $98.84 $4,445 - $4,942	-50 Reduced 0.8%	6,190 $585,000
Q1 2018 Apr 10, 2018	BUY	$92.01 - $123.21 $96,150 - $128,754	1,045 Added 20.12%	6,240 $590,000
Q4 2017 Jan 16, 2018	BUY	$89.56 - $98.21 $4,478 - $4,910	50 Added 0.97%	5,195 $502,000
Q3 2017 Oct 20, 2017	BUY	$69.85 - $89.22 $359,378 - $459,036	5,145	5,145 $457,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norway Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norway Savings Bank with notifications on news.

Account

Norway Savings Bank Abb Vie Inc. Transaction History